NeuroMetrix announces issuance of U.S. patent for Quell Wearable Pain Relief Technology
NeuroMetrix announced that the USPTO has issued U.S. Patent No. 9,656,070. The patent covers the novel application of real-time accelerometer measurements to control transcutaneous electrical nerve stimulation. This core technology enables several advanced Quell® features. May 22, 2017